To test the effect of D9 on LSCs, we used TF-la, an AML primitive myeloid progenitor cell line, which has a high fraction of stem-like CD34+CD38- cells and thus considered as an excellent model for studying LSC [38]. The gene discussed is CD38; the disease is acute myeloid leukemia.